Related Experiment Videos
Novel biologically based therapies for multiple myeloma
Nikhil C Munshi1, Teru Hideshima, Dharminder Chauhan
1The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
International Journal of Hematology
|November 15, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation.
Blood cancer discovery·2021
A 3D-Bioprinted Multiple Myeloma Model.
Advanced healthcare materials·2021
Therapeutic drug monitoring guides personalized ponatinib dose reduction for chronic myeloid leukemia.
International journal of hematology·2026
Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome.
International journal of hematology·2026
Incidence, etiology, and predictors of early mortality after induction chemotherapy for aml in a middle-income country.
International journal of hematology·2026
Modified short-course fludarabine-based conditioning regimen for salvage cord blood transplantation after graft failure.
International journal of hematology·2026
Cytarabine-based induction and oral maintenance therapy for a single system with single-site Langerhans cell histiocytosis.
International journal of hematology·2026
Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.
International journal of hematology·2026
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.
Frontiers in genetics·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026